CAMP Q3 2024 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$14M

Net Income

-$13M

EPS (Diluted)

$-0.69

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$21M

Total Liabilities

$180M

Stockholders' Equity

-$159M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$350,000	-100.0%
Gross Profit	$0	$350,000	-100.0%
Operating Income	-$14M	-$12M	-9.5%
Net Income	-$13M	-$12M	-15.3%